This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Sanja Stevanovic: Innovator in Cancer Immunotherapy
Introduction
Sanja Stevanovic is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of cancer immunotherapy, particularly through her innovative work on T cell receptors.
Latest Patents
Sanja holds a patent for Anti-KK-LC-1 T cell receptors. This patent discloses an isolated or purified T cell receptor (TCR) that has antigenic specificity for Kita-Kyushu Lung Cancer Antigen 1 (KK-LC-1). The patent also includes related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions. Additionally, it outlines methods for detecting the presence of cancer in mammals and methods for treating or preventing cancer in mammals.
Career Highlights
Sanja Stevanovic works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her role in this esteemed organization highlights her commitment to advancing healthcare and cancer treatment.
Collaborations
Sanja collaborates with Christian S. Hinrichs, further enhancing her research and contributions to the field of cancer immunotherapy.
Conclusion
Sanja Stevanovic's innovative work and patent in cancer immunotherapy demonstrate her dedication to improving treatment options for cancer patients. Her contributions are vital in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile